Skip to main content
Joel Saper, MD, Neurology, Ann Arbor, MI

JoelRSaperMD

Neurology • Ann Arbor, MI

Headache, Pain Medicine

Founder/Director of Michigan Headache & Neurological Institute

Join to view full profile

Dr. Saper is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Saper's full profile

Already have an account?

  • Office

    3120 Professional Dr
    Ann Arbor, MI 48104
    Phone+1 734-677-6000
    Fax+1 734-677-2422

Education & Training

  • University of Michigan
    University of MichiganResidency, Neurology, 1970 - 1973
  • Michael Reese Hospital and Medical Center
    Michael Reese Hospital and Medical CenterInternship, Internal Medicine, 1969 - 1970
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1969

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1971 - 2027
  • IL State Medical License
    IL State Medical License 1970 - 2017
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2003-2014
  • Women's Health Castle Connolly, 2008
  • Men's Health Castle Connolly, 2007

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Post Concussion Migraine: How a Head Injury Might Change Your Headache Condition or Result in Photophobia
    Post Concussion Migraine: How a Head Injury Might Change Your Headache Condition or Result in PhotophobiaFebruary 7th, 2020
  • My Migraines Keep Coming Back – the Insanity of Medication Overuse Headaches (MOH)
    My Migraines Keep Coming Back – the Insanity of Medication Overuse Headaches (MOH)October 19th, 2019
  • Alder BioPharmaceuticals® to Present New Analyses of Eptinezumab’s Clinical Trial Data Describing Early, Robust Migraine Prevention and Quality of Life Impact at 2019 American Academy of Neurology Annual Meeting
    Alder BioPharmaceuticals® to Present New Analyses of Eptinezumab’s Clinical Trial Data Describing Early, Robust Migraine Prevention and Quality of Life Impact at 2019 American Academy of Neurology Annual MeetingApril 23rd, 2019
  • Join now to see all

Professional Memberships

Dr. Joel Saper, Dr. Joel Saper, MD, Dr. J Saper, Dr. Joel R Saper